|« Previous month||Next month »|
29-Mar-2012 - BASF has announced plans to restructure its R&D operations, citing solubility enhancing excipients as an opportunity for growth.
29-Mar-2012 - Teva is to sell its Quebec, Canada manufacturing facility and transfer 150 employees to US CMO Halo Pharmaceuticals.
29-Mar-2012 - An academic has questioned the wisdom of longer maximum penalties for counterfeiters at a House meeting to discuss sentencing.
28-Mar-2012 - The FDA has hit two Mexican companies with GMP warning letters six months after inspectors visited the country.
28-Mar-2012 - in-PharmaTechnologist present its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Delcath, Genesis and Intarcia.
28-Mar-2012 - In the first six months of fiscal 2011 tests of drug samples found 1,420 substandard pharmaceuticals in India.
27-Mar-2012 - Novasep says it may invest in active pharmaceutical ingredients (API) bioproduction and purification technology citing growing industry demand.
27-Mar-2012 - Ideal Cures has been granted a US patent for an immediate release film coating tech that - it claims - could rid the Pharma production sector of solvents.
27-Mar-2012 - The Pharmaceutical Inspection Cooperation Scheme (PIC/S) has welcomed Japan’s application for membership.
27-Mar-2012 - More than four-fifths of anti-malarials sampled in Nigeria failed to meet USP specifications for one of the APIs, researchers found.
26-Mar-2012 - Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry...
26-Mar-2012 - The US FDA is keeping its estimate of the burden imposed by electronic facility registration despite some industry opposition.
26-Mar-2012 - The US FDA must consider the cumulative impact of regulations on small firms to prevent its actions from suppressing growth, the White House said.
22-Mar-2012 - GSK has made good on its promise to invest in the UK, confirming plans to spend £500m ($789m) on new manufacturing capacity in the country just a day after the...
22-Mar-2012 - Experience handling the wave of drug shortages in the US can improve disaster response plans, the IOM wrote.
22-Mar-2012 - Health Canada officials are working “around the clock” to approve 23 new drug applications in one month to combat national meds shortages caused by troubles at Sandoz.
22-Mar-2012 - IPEC Americas wants member input for US Food and Drug Administration (FDA) inactive ingredient database (IID) subcommittee.
21-Mar-2012 - Indian API manufacturers may dominate the list of companies that have had CEPs suspended this year, but that may say more about inspection policies than it does about standards outside...
21-Mar-2012 - Formac Pharmaceuticals and WR Grace say their silica platform can improve the formulation selection process for poorly soluble APIs (active pharmaceutical ingredients).
21-Mar-2012 - March has already been a busy month for the biomanufacturing technology sector and here is in-Pharmatechnologist.com’s round-up of some of the developments so far.
21-Mar-2012 - Teva will try to use different delivery devices for biosimilars to gain an edge over innovator products, its North American CEO said.
20-Mar-2012 - Sigma Aldrich says new packaging facility in China will shorten supply chains and help it build in an increasingly important regional market.
20-Mar-2012 - Generic API (active pharmaceutical ingredient) makers should consider the off-patent potential of a drug as soon as it is launched, according to a new study by PharmaIntellect.
20-Mar-2012 - The US FDA will today publish a final rule to change cGMP labelling controls, 15 years after proposing the revision.
20-Mar-2012 - in-PharmaTechnologist presents its weekly round-up of the latest new appointments within the pharmaceutical industry, including news from Thermo Fisher, Stemline and ImmunoCellular.
20-Mar-2012 - Indian drugmakers will increase investment in GMP compliance to avoid becoming the next company hit by the FDA, a credit rating agency said.
19-Mar-2012 - More bad news for troubled CMO Ben Venue Laboratories after European regulators recommend that production of two more drugs – Caelyx and Ceplene – is relocated to other facilities.
19-Mar-2012 - The UK’s biggest trade union Unite has lashed out at Sanofi branding its plan to close a plant in Newcastle, England, as “unacceptable”.
19-Mar-2012 - The FDA has published a 483 detailing some of the 400 customer complaints that led to it sending a warning letter to APP Pharmaceuticals.
15-Mar-2012 - German chemicals giant BASF has contracted Connell Brothers as its drug excipients distributor in Australia and New Zealand.
15-Mar-2012 - The US DEA is increasing manufacturers’ annual controlled substance fees by 30 per cent from next month.
15-Mar-2012 - in-PharmaTechnologist presents its weekly round-up of the latest appointments in the pharmaceutical industry, including news from SciFluor, NinePoint and Abbott India.
15-Mar-2012 - Apotex is suing the US government over an import alert it claims was unjust and had a “devastating impact” on business.
14-Mar-2012 - Bend Research has licensed its spray-dried dispersion technology to Affinium, adding to similar deals with Eli Lilly and Merck & Co.
14-Mar-2012 - UK drug major AstraZeneca has contracted BioFocus and Argenta to provide it with discovery services just weeks cutting its internal R&D capacity.
14-Mar-2012 - The UK MHRA wants Pharmas to share their thoughts on the regulations governing the industry – including those on manufacturing and safety – under the UK Government’s ‘Red Tape Challenge.’
14-Mar-2012 - Generics and API maker Ranbaxy has opened a plant in Casablanca, Morocco in a bid to strengthen its foothold in the “increasingly important” North African drugs market.
14-Mar-2012 - The US FDA has sent Warner Chilcott a warning letter outlining five years of manufacturing failings at its Puerto Rico plant.
13-Mar-2012 - Canada’s Centre for Commericalisation of Regenerative Medicines (CCRM) has partnered with Merck Millipore to develop optimized methodologies for bioreactor-based stem cell cultivation.
13-Mar-2012 - Acuros is seeking development partnerships with Big Pharma over its recently launched water-powered drug delivery pump.
13-Mar-2012 - GSK will launch an apprenticeship programme later this year to train young people in a range of industry disciplines, including manufacturing, R&D and supply chain management.
13-Mar-2012 - The US FDA wants UAE-based Gulf Pharmaceutical Industries to hire a third-party auditor to fix data integrity failings outlined in a warning letter.
12-Mar-2012 - BioDelivery Sciences International (BDSI) has postponed the ‘relaunch’ of its pain drug Onsolis to give it more time to modify the formulation.
12-Mar-2012 - The US FDA’s Center for Drug Evaluation and Research (CDER) has published the list of guidance documents it aims to issue this year.
12-Mar-2012 - The EMA plans to update its excipient guidelines to cover safety concerns surrounding use in children and pregnant women.
12-Mar-2012 - The TGA will audit manufacturing processes at CSL Biotherapies after a fractured tank led to ethylene glycol contamination.
08-Mar-2012 - Filtration and processing tech firm Pall Life Sciences’ biopharmaceutical business made the biggest contribution to its revenues revenues in fiscal Q2.
08-Mar-2012 - GE Healthcare has announced plans to buy US production tech firm Xcellerex, continuing its efforts to build its biomanufacturing offering.
08-Mar-2012 - GlaxoSmithKline (GSK) and Astrazeneca have each funded new nuclear magnetic resonance (NMR) research at the University of Warwick, UK which could improve the QC process for drugsmakers.
08-Mar-2012 - The Greek government has asked several drugmakers to accept losses on bonds originally issued to cover unpaid bills.
07-Mar-2012 - The joint US FDA and EMA active pharmaceutical ingredient (API) manufacturing facility inspection programme has signed up the World Health Organisation as a member.
07-Mar-2012 - in-PharmaTechnologist presents its weekly round-up of the latest changes within the pharmaceutical industry, including news from Akorn, Anthera and Alkermes.
07-Mar-2012 - Medicago has finalised a research collaboration agreement with Mitsubishi Tanabe Pharma Corporation for the development of new VLP vaccines.
06-Mar-2012 - The US FDA is asking manufacturers to reformulate products containing DBP and DEHP excipients to cut the risk of toxicity.
06-Mar-2012 - The Society of Chemical Manufacturers and Affiliates’ (SOCMA) Bulk Pharmaceutical Task Force (BPFT) has reiterated its support for the generic drug user fees act (GDUFA) debated last month .
06-Mar-2012 - The EMA wants manufacturers using herbal starting materials to assess the substances’ initial and post-processing contaminant profile.
05-Mar-2012 - Danadams' CEO Yaw Adu Gyamfi will tomorrow meet with the Ghanaian Government urging them to establish a drugs fund which will see more meds manufacturing in the country.
05-Mar-2012 - Regulation over combination products must be simplified to get products to market quicker, said Marielle Fournier, director of Voisin Life Sciences Consulting.
05-Mar-2012 - Amgen has called FDA draft guidance on API-excipient co-crystals unnecessary in its written response to the Agency.
01-Mar-2012 - The drug excipient industry wants the Chinese Pharmacopoeia Committee (CPC) to harmonise monographs with international compendia says IPEC Americas.
01-Mar-2012 - The FDA has raised its limit on the bead size for drugs delivered by sprinkling after big pharma firms criticised its draft guidance.
01-Mar-2012 - The UN has urged Governments to crack down on the growing number of fake drugs being sold online.
|« Previous month||Next month »|